Newsroom | 17906 results
Sorted by: Latest
-
HealthView CEO Steven Gonzalez Announces Upcoming Inc. Article, “Your Best People Burn Out”
CERRITOS, Calif.--(BUSINESS WIRE)--A new thought leadership piece from HealthView Home Health, Hospice & Palliative Care President & CEO Steven Gonzalez is set for release on Inc.com, titled “Your Best People Burn Out.” The article builds on the ideas introduced in his widely engaged LinkedIn Culture Lab Post #76 and elevates the conversation to a national business audience. In the upcoming piece, Gonzalez challenges a common leadership blind spot: the quiet burnout of high performers....
-
WELL Health to Report Fourth Quarter and Year End 2025 Financial Results on March 19, 2026
VANCOUVER, British Columbia--(BUSINESS WIRE)--WELL Health Technologies Corp. (TSX: WELL, OTCQX: WHTCF) (the “Company” or “WELL”), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that the Company will release its Fiscal Fourth Quarter and Year End 2025 financial results for the period ended December 31, 2025, before market open on Thursday, March 19, 2026....
-
McKesson Corporation Announces Fourth Quarter Fiscal 2026 Earnings Release Date and Participation in Upcoming Conferences
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its fourth quarter fiscal 2026 financial results after market close on Thursday, May 7, 2026. Chief Executive Officer Brian Tyler and Chief Financial Officer Britt Vitalone will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. Mr. Vitalone will be participating in Leerink Partners Global Healthcare Conference and Barclays Global Healthcare Confe...
-
Samenvatting: GAIA en Daiichi Sankyo Europe sluiten een exclusief partnerschap om digitale therapieën voor cardiovasculaire zorgverlening van de nieuwe generatie in Europa te lanceren.
HAMBURG, Duitsland & MÜNCHEN--(BUSINESS WIRE)--GAIA, de pionier in evidence-based digitale therapieën, en Daiichi Sankyo Europe, kondigden vandaag een exclusief strategisch partnerschap aan om lipodia te commercialiseren na het verkrijgen van wettelijke goedkeuring1. Deze digitale therapie is ontworpen ter ondersteuning van volwassenen getroffen door hypercholesterolemie. De uitgebreide samenwerking verenigt GAIA’s jarenlange expertise in het ontwikkelen van klinisch gevalideerde, niet-farmacol...
-
Riassunto: GAIA e Daiichi Sankyo Europe firmano un accordo di partnership esclusiva per lanciare la terapia digitale di nuova generazione per la cura cardiovascolare in Europa.
AMBURGO, Germania e MONACO--(BUSINESS WIRE)--GAIA, azienda pioniera nella terapia digitale basata sull'evidenza e Daiichi Sankyo Europe, oggi hanno annunciato un'esclusiva partnership strategica per commercializzare lipodia previa autorizzazione normativa1. Questa terapia digitale è progettata per supportare la convivenza con l'ipercolesterolemia. La collaborazione completa riunisce le competenze di lunga data di GAIA nello sviluppo clinicamente convalidato di interventi non farmacologici con l...
-
GAIA et Daiichi Sankyo Europe concluent un partenariat exclusif pour lancer une thérapie numérique de nouvelle génération pour les soins cardiovasculaires en Europe.
HAMBOURG, Allemagne et MUNICH--(BUSINESS WIRE)--GAIA, pionnier des thérapies numériques fondées sur des preuves, et Daiichi Sankyo Europe ont annoncé aujourd’hui un partenariat stratégique exclusif pour commercialiser lipodia dès son autorisation réglementaire1. Cette thérapie numérique est conçue pour aider les adultes souffrant d’hypercholestérolémie. Cette collaboration globale associe l’expertise de longue date de GAIA dans le développement d’interventions non pharmacologiques validées clin...
-
Resumen: GAIA y Daiichi Sankyo Europe firman un acuerdo de colaboración exclusiva para lanzar en Europa un tratamiento digital de última generación para el cuidado cardiovascular.
HAMBURGO, Alemania y MÚNICH--(BUSINESS WIRE)--GAIA, pionera en terapias digitales basadas en pruebas, y Daiichi Sankyo Europe han anunciado hoy una colaboración estratégica exclusiva para comercializar Lipodia una vez obtenida la aprobación reglamentaria1. Esta terapia digital está diseñada para ayudar a los adultos que padecen hipercolesterolemia. Esta colaboración integral aúna la amplia experiencia de GAIA en el desarrollo de intervenciones no farmacológicas clínicamente validadas con la imp...
-
Phreesia’s Tara Sheehy Named to MM+M Women to Watch
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia's Tara Sheehy, Senior Director of Client Experience for Phreesia Network Solutions, has been named to the MM+M Women to Watch class of 2026....
-
CareDx Announces VANTx™, an AI‑Powered Clinical Data & Analytics Platform Built on CareDx’s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant patients and caregivers, today announced the launch of VANTx™, an AI‑powered, cloud‑native clinical data and analytics platform designed to transform complex transplant data into insights that support clinical research and real‑world...
-
Next Health Enters Washington, Opening First State Location in Bellevue as Longevity Demand Accelerates
BELLEVUE, Wash.--(BUSINESS WIRE)--Next Health expands to Washington with its first state location in Bellevue, bringing advanced health optimization & longevity services to the region....